The Journey from Molecule to Medicine – A Photo Tour Click on the arrows to see the path a discovery takes toward becoming a potential treatment. Image Gallery Chemist Matthew Disney’s group develops new ways to find medicines that act on disease-causing RNA.… Louis Scampavia, Ph.D., and Timothy Spicer, Ph.D.,…
Every Cure Begins With understanding…
Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.
A gene called Syngap1 enables touch-based perception, while certain mutations can lead to mixed signals, a new study finds.
Memory depends on a symphony of crucial molecules, each playing their part in harmony. Neuroscientist Sathya Puthanveettil, Ph.D., studies how this harmony can change brain connections during learning to create and keep memories. His findings could eventually lead to treatments to improve memory function. Driving the News: When the…
Children born with a damaged gene needed for healthy brain development, SYNGAP1, experience seizures, sensory processing disorders, difficulty speaking, intellectual disability, and autism-like behaviors. It’s a condition without any treatments, one that’s hard both on parents and children, said Gavin Rumbaugh, Ph.D., a neuroscientist at The Herbert Wertheim…
Molecular biologist Ezgi Hacisuleyman, Ph.D., investigates how neurons respond to signals, changing in milliseconds. She recently joined the institute from The Rockefeller University.
Hattori focuses on understanding and mapping how the brain integrates information to make decisions.
Part of the graduate program’s Distinguished Lecture Series, Capecchi’s talk described using the same mouse genetics research methods that earned him the Nobel Prize in 2007.
Neuroscientist Sathya Puthanveettil, Ph.D., has documented the packets of material that move from neuron body to synapse during memory formation.
